Assessment of the impact of COVID-19 on pregnancy care and outcomes

Information on COVID-19-related morbidity and mortality in pregnant women and neonates is currently unclear. There are significant variations in prenatal, intrapartum, and postpartum care, and limited to routine surveillance or diagnosis of COVID-19 syndrome. It is not clear what changes are possible in clinical care, community support, home support and birth care. These changes or errors are likely to bear the greatest adverse effects of the COVID-19 pandemic in Indonesia. There is therefore an urgent need to quantify the estimated impact of COVID-19 on morbidity and mortality in pregnant women and infants, and explore data-driven digital interventions. data and monitoring methods to develop risk reduction strategies. - Hypothesis The unmeasured high morbidity and mortality associated with COVID-19 among pregnant women and infants in Indonesia is due to inadequate antenatal, intrapartum and postpartum care, self-care not doing well during social distancing and due to exposure to the virus during pregnancy. - Target To document gaps in antenatal, birth and postpartum care and delivery practices in maternity clinics and community care due to changes in the health system. To estimate the excess morbidity and mortality associated with COVID-19 in pregnant women and infants due to the above problems and exposure/infection to the virus.